Thyroid disease

Coxa Vara Deformity in Fibrous Dysplasia/ McCune‐Albright Syndrome: Prevalence, Natural History and Risk Factors: A Two‐Center Study

J Bone Miner ResPublished Two-center cohort study with nested case-control analysis

Authors' conclusion

In conclusion, in tertiary care centers, the prevalence of FD/MAS coxa vara deformity was 36%. Risk factors included presence of MAS, high percentage of femur affected, calcar destruction, radiolucency, NSA <120 degrees and age < 15 years.

Study context

Population
Patients <30 years with any subtype of FD/MAS, FD involving the proximal femur and ≥1 X-ray; National Institutes of Health and Leiden University Medical Center274 FD femurs
Participants
180 patients
Outcome
Prevalence of coxa vara deformity (NSA <110 degrees or >10 degrees below age-specific values)
Methodological detailslinear mixed effects model
  • Linear mixed effects model

Main finding

As reported in the abstract

Prevalence of varus deformity

Femurs with varus deformity

99

36%

Observational data: associations, not effects.

Further findings

Risk factors for deformity, nested case-control analysis

Presence of MAS
P < 0.001
Hyperthyroidism
P < 0.001
Hypophosphatemia
P < 0.001
High percentage of femur affected
P < 0.001
Calcar destruction
P < 0.001

Risk factors for temporal neck-shaft angle (NSA) decrease, linear mixed effects model

GH excess
β = 7.2, p = 0.013
Hyperthyroidism
β = 11.3, p < 0.001
>25% of the femur affected
β = 13.2, p = 0.046
Calcar destruction
β = 8.3, p = 0.004
Radiolucency
β = 3.9, p = 0.009
Bilateral involvement
β = 9.8, p = 0.010
Most progression of deformity if NSA <120 degrees with age < 15 years (visual inspection)
  • 114 femurs (non-operated, ≥2 X-rays)

Original publication

Coxa Vara Deformity in Fibrous Dysplasia/ McCune‐Albright Syndrome: Prevalence, Natural History and Risk Factors: A Two‐Center Study. J Bone Miner Res. Published 21 May 2023. doi:10.1002/jbmr.4818

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.